Mora Paz, Rubio Vicente, Cervera Javier
Instituto de Investigaciones Citológicas (FVIB), Valencia 46010, Spain.
FEBS Lett. 2002 Jan 30;511(1-3):6-10. doi: 10.1016/s0014-5793(01)03246-x.
We use site-directed mutagenesis to clarify the role of effector-mediated oligomerization changes on the modulation of the activity of Escherichia coli carbamoyl phosphate synthetase (CPS) by its allosteric activator ornithine and its inhibitor UMP. The regulatory domain mutations H975L, L990A and N992A abolished, and N987V decreased CPS oligomerization. The oligomerization domain mutation L421E prevented tetramer but not dimer formation. None of the mutations had drastic effects on enzyme activity or changed the sensitivity or apparent affinity of CPS for ornithine and UMP. Our findings exclude the involvement of oligomerization changes in the control of CPS activity, and show that CPS dimers are formed by the interactions across regulatory domains, and tetramers by the interactions of two dimers across the oligomerization domains. A mechanism for effector-mediated changes of the oligomerization state is proposed.
我们使用定点诱变来阐明效应物介导的寡聚化变化对大肠杆菌氨甲酰磷酸合成酶(CPS)活性调节的作用,该酶的变构激活剂为鸟氨酸,抑制剂为UMP。调节结构域突变H975L、L990A和N992A消除了CPS的寡聚化,而N987V降低了CPS的寡聚化。寡聚化结构域突变L421E阻止了四聚体的形成,但不影响二聚体的形成。这些突变均未对酶活性产生显著影响,也未改变CPS对鸟氨酸和UMP的敏感性或表观亲和力。我们的研究结果排除了寡聚化变化参与CPS活性控制的可能性,并表明CPS二聚体是由调节结构域之间的相互作用形成的,而四聚体是由两个二聚体通过寡聚化结构域之间的相互作用形成的。我们提出了一种效应物介导的寡聚化状态变化的机制。